Latest filing published 19 Apr 2012 for BG Medicine, Inc., €1.0M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -2.5%Entry 33.92 · Close at T+365 33.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Pieter van der Meer: trading record in brief
Pieter van der Meer discloses dealings in BG Medicine, Inc. to SEC (Form 4). We count 4 filings; the first trade dates from 9 February 2011 and the latest from 17 April 2012.
Market trades split into 1 purchase (€734k) and 1 sale (€1.0M). Sales outweigh purchases by €271k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2012 to date brings no purchases and 1 sale.
The newest entry dates from 19 April 2012: an open-market sale of €1.0M, in BG Medicine, Inc. The clock since the last published purchase (11 February 2011) now reads 5,750 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Pieter van der Meer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200,000 shares@ US$6.60Common StockSEC:0001181431-12-024841:0
- 151,450 shares@ US$7.00Common StockSEC:0001181431-11-009589:1
- 1,541,125 sharesCommon StockSEC:0001181431-11-009589:0
- 142,857 shares@ US$7.00Common StockSEC:0001181431-11-009589:2Canonical exit: 10 May 2011 (T+90)
4 of 4 declarations
